<bill session="109" type="s" number="1487" updated="2023-01-13T04:50:23Z">
  <state datetime="2005-07-26">REFERRED</state>
  <status>
    <introduced datetime="2005-07-26"/>
  </status>
  <introduced datetime="2005-07-26"/>
  <titles>
    <title type="display">A bill to suspend temporarily the duty on Sorafenib.</title>
    <title type="official" as="introduced">A bill to suspend temporarily the duty on Sorafenib.</title>
  </titles>
  <sponsor bioguide_id="S000059"/>
  <cosponsors/>
  <actions>
    <action datetime="2005-07-26">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2005-07-26" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Foreign trade and international finance"/>
    <term name="Chemicals"/>
    <term name="Drugs"/>
    <term name="Health"/>
    <term name="Tariff"/>
  </subjects>
  <amendments/>
  <summary date="2005-07-29T19:55:22Z" status="Introduced in Senate">Amends the Harmonized Tariff Schedule of the United States to suspend, through December 31, 2009, the duty on Sorafenib tosylate.</summary>
</bill>
